Data / Form D filings / Mel-Mont Medical, Inc.
Mel-Mont Medical, Inc.: Form D filings
Mel-Mont Medical, Inc., a biotechnology company in Doral, FL, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on December 17, 2025, reports $250,000 sold of a $5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11467 NW 34TH STREET, Doral, FL, 33178
- Phone
- (305) 335-6162
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1832591
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | New notice | $5,000,000 | $250,000 | $4,750,000 | 3 | Dec 11, 2025 | sec.gov |
| Dec 16, 2025 | Amendment | $7,500,000 | $6,902,021 | $597,979 | 69 | Aug 25, 2023 | sec.gov |
| Sep 21, 2023 | New notice | $7,500,000 | $50,000 | $7,450,000 | 1 | Aug 25, 2023 | sec.gov |
| Nov 20, 2020 | New notice | $3,000,000 | $3,000,000 | 1 | Oct 30, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Torres | Executive Officer | |
| Octavio Gonzalez Paredo | Executive Officer, Director | |
| Liliana Montes | Executive Officer, Director | |
| Frank Melendez | Executive Officer, Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mel-Mont Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.